Education
About Us
Working with TipRanks
Follow Us
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
Earnings Data
Report Date
Nov 05, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.75Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected strong revenue and dosage growth, successful launches, and strategic positioning for future growth through regulatory and market dynamics. However, increased costs and cash flow challenges were noted, along with uncertainties in IDN fulfillment rates.Company Guidance
Significant Revenue Growth
scPharmaceuticals generated $16 million in net revenue for Q2 2025, marking a 99% increase over Q2 2024.
FUROSCIX Doses Increase
Approximately 20,200 FUROSCIX doses were filled, representing a 117% increase over Q2 2024 and a 45% increase over Q1 2025.
Nephrology Launch Success
The nephrology launch of FUROSCIX showed faster adoption rates by nephrologists compared to cardiologists, with higher doses per prescription.
IDN Business Growth
The Integrated Delivery Network (IDN) business grew by 70% quarter-over-quarter, becoming a significant part of total sales.
Positive Impact of Medicare Part D Dynamics
An increasing number of Part D patients reached their out-of-pocket maximums, positively impacting Q2 performance and expected to enhance future market penetration.
Regulatory and Strategic Advancements
The anticipated submission of the SNDA for the auto-injector and the CMS proposed ambulatory specialty model are expected to provide future growth opportunities.
SCPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SCPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $5.01 | $4.63 | -7.58% |
May 14, 2025 | $2.24 | $2.88 | +28.57% |
Mar 19, 2025 | $3.04 | $3.01 | -0.99% |
Nov 13, 2024 | $3.91 | $3.36 | -14.07% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does scPharmaceuticals Inc (SCPH) report earnings?
scPharmaceuticals Inc (SCPH) is schdueled to report earning on Nov 05, 2025, TBA (Confirmed).
What is scPharmaceuticals Inc (SCPH) earnings time?
scPharmaceuticals Inc (SCPH) earnings time is at Nov 05, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SCPH EPS forecast?
SCPH EPS forecast for the fiscal quarter 2025 (Q3) is -0.23.
